论文部分内容阅读
抽取有代表性的3家医院为研究单位，调查分析这些医院1993～1995年消耗的NSAIDS品种及消耗量。以了解临床上使用的NSAIDs的产品结构、预测其发展趋势。为NSAIDs新产品的开发利用和临床合理有效地选择NSAIDs提供依据。调查表明，这3家医院中NSAIDs的应用有些新的发展，某些疗效好、不良反应少的药物逐渐引入临床，但毒性大的老品种仍占一定的比例，品种结构单调，复方制剂组方雷同化，剂型以普通片剂或肠溶衣片为多见（70％）。面对这些问题，尚需加强新制剂、新品种及多种规格的制剂的开发与引进，使临床使用NSAIDS类药物品种结构更趋于合理。
Three representative hospitals were selected as research units to investigate and analyze the NSAIDS species and consumption consumed by these hospitals from 1993 to 1995. To understand the product structure of clinically used NSAIDs and predict its development trend. It provides the basis for the development and utilization of new products of NSAIDs and clinical selection of NSAIDs. The investigation shows that the application of NSAIDs in these three hospitals has undergone some new developments. Some drugs with good curative effects and few adverse reactions have gradually been introduced into the clinic. However, the old varieties with high toxicity still account for a certain proportion. The structure of the varieties is monotonous, and the compound preparations are monotonous. Assimilation, the dosage form is more common with common tablets or enteric-coated tablets (70%). In the face of these problems, the development and introduction of new preparations, new varieties, and various specifications of preparations must be strengthened, so that the structure of clinical use of NSAIDS drugs is more reasonable.